Preliminary Results for the Year Ended 31 December 2023
Wall Street Online Denmark,
19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
Please enter a search term. Please enter a search term. News provided by Apr 19, 2024, 8:00 AM ET 19 April 2024 Biodexa…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
("Biodexa" or the "Company" or, together with its subsidiaries, the "Group") Biodexa Pharmaceuticals PLC BDRX, a clinical stage…
19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a…
19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company" or, together with its subsidiaries, the "Group"…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
Please enter a search term. Please enter a search term. News provided by Apr 28, 2023, 4:30 PM ET 28 April 2023 Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
28 April 2023 ("Biodexa" or the "Company" or, together with its subsidiaries, the "Group") Biodexa Pharmaceuticals PLC BDRX, a…
28 April 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Biodexa…
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective Midatech Pharma PLC (A…
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON…
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON…
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON…
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON…
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON…
ABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13, 2021 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology…
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON…
13 December 2021 Midatech Pharma PLC ("Midatech" or the "Company") Investigational New Drug Application for Study of MTX110 in…